Provided by Tiger Trade Technology Pte. Ltd.

Vascular Biogenics

5.46
0.0000
Volume:- -
Turnover:968.74K
Market Cap:12.11M
PE:-0.76
High:5.46
Open:5.46
Low:5.46
Close:5.46
52wk High:11.20
52wk Low:3.53
Shares:2.22M
Float Shares:1.65M
Volume Ratio:- -
T/O Rate:- -
Dividend:- -
Dividend Rate:- -
EPS(TTM):-7.1678
EPS(LYR):-14.5786
ROE:-59.52%
ROA:-29.12%
PB:0.63
PE(LYR):-0.37

Loading ...

Company Profile

Company Name:
Vascular Biogenics
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
- -
Office Location:
- -
Zip Code:
- -
Phone:
- -
Fax:
- -
Introduction:
Vascular Biogenics Ltd., a biopharmaceutical company, develops therapeutics for the treatment of cancer and immune-inflammatory diseases in Israel and the United States. It develops VB-601 using monocyte targeting technology for various inflammatory indications. The company was formerly known as Medicard Ltd. and changed its name to Vascular Biogenics Ltd. in January 2003. Vascular Biogenics Ltd. was incorporated in 2000 and is headquartered in Modi'in, Israel.